Inventor · disambiguated record
David A. Sirbasku
Also filed as: SIRBASKU DAVID · SIRBASKU DAVID A
7 granted patents·4 pending applications·15 citations·filing 1984–2012
78Inventor score
Top patents by PatentIndex Score
11 records- 0168US7947275B2Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growthSIGNE BIOPHARMA INC·Filed 2001·Granted May 24, 2011·2 cites·26 claims
- 0266US8038999B2Breast cancer eradication programSIRBASKU DAVID A·Filed 2007·Granted Oct 18, 2011·0 cites·36 claims
- 0366US7863011B2Screening method for predicting susceptibility to breast cancerSIGNE BIOPHARMA INC·Filed 2002·Granted Jan 4, 2011·1 cites·11 claims
- 0461US7947463B2Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancersSIGNE BIOPHARMA INC·Filed 2001·Granted May 24, 2011·2 cites·14 claims
- 0554US2003072812A1Breast cancer eradication programSIRBASKU DAVID A·Filed 2002·Application pending·0 cites
- 0652US8563249B2Receptor gene screening for detecting or diagnosing cancerSIRBASKU DAVID A·Filed 2011·Granted Oct 22, 2013·0 cites·22 claims
- 0750US2012034206A1Breast cancer eradication programSIRBASKU DAVID·Filed 2011·Application pending·0 cites
- 0847US4670539APeptide growth factors derived from estrogen responsive kidney tissueUNIV TEXAS·Filed 1984·Granted Jun 2, 1987·10 cites·3 claims
- 0947US2012121620A1Anti-estrogen and immune modulator combinations for treating breast cancerSIRBASKU DAVID A·Filed 2012·Application pending·0 cites
- 1045US2011086800A1Screening method for predicting susceptibility to breast cancerSIRBASKU DAVID A·Filed 2010·Application pending·0 cites
- 1143US8119138B2Anti-estrogen and immune modulator combinations for treating breast cancerSIRBASKU DAVID A·Filed 2002·Granted Feb 21, 2012·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when David A. Sirbasku files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →